Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Affymax researches potential malaria vaccines

Dec. 16, 1996

University of Alberta discovers new chemokine-binding protein

Dec. 16, 1996

British Biotech reports new MMP inhibitors

Dec. 16, 1996

New ET-1 inhibitors from Ciba-Geigy

Dec. 16, 1996

Toray reports peptides for toxic shock syndrome

Dec. 16, 1996

Eisai describes selective dopamine D3 antagonists

Dec. 16, 1996

Novel anticancer agents from Sankyo

Dec. 16, 1996

Antiallergic/antiasthmatic compounds disclosed by Dainippon Ink

Dec. 16, 1996

Antiinflammatory glycolipid compounds from Nissin Food Products

Dec. 16, 1996

New antitussive agent from Snow Brand Milk Products

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...